Story

U.S. Stocks Open Higher on Softer Inflation Data; PayPal Surges on Takeover Report

ENTHMSVIIDZHZH-TWJAKOHI
Jul 15, 20261 min read
U.S. Stocks Open Higher on Softer Inflation Data; PayPal Surges on Takeover Report

Summary

Major U.S. indexes gained at the opening bell, buoyed by a cooler-than-expected producer inflation report and a significant jump in PayPal shares following news of a reported $53 billion buyout offer.

Text size
Background

U.S. stock indexes opened higher on Wednesday as investors assessed cooler-than-expected producer inflation data and reacted to reports of a major takeover bid for PayPal. The positive sentiment at the opening bell was broad-based across the major averages, according to a report from Reuters.

Market Snapshot at the Open

The three main U.S. stock indexes posted solid gains at the start of the trading session on July 15:

  • The Dow Jones Industrial Average rose 95.9 points, or +0.18%, to 52,604.2.
  • The S&P 500 gained 28.1 points, or +0.37%, to 7,571.72.
  • The Nasdaq Composite advanced 154.2 points, or +0.59%, to 26,261.183.

Key Drivers: Inflation and M&A

Sample IUX Markets – In-articleAd

A primary catalyst for the morning's optimism was a report showing softer-than-expected producer inflation. Such data can ease investor concerns about persistent price pressures, which could influence future Federal Reserve monetary policy decisions.

In company-specific news, shares of PayPal surged more than 15% in early trading. The sharp increase followed a report of a $53 billion takeover offer for the payments company, making it a standout performer at the market open.

Earnings Season in Focus

The market's positive start comes as investors continue to digest a flurry of corporate earnings reports. This earnings season provides a crucial look into corporate health and forward-looking guidance, offering insight into how companies are navigating the current economic environment.

Read next

More on Stocks
Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Stocks

Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Sep 20, 2026

Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) has resubmitted its application for a main board listing on the Hong Kong Stock Exchange, aiming to secure a dual listing to access international capital. The company specializes in drugs for central nervous system and cardiovascular diseases.

Back to latest news

LATEST